Affordable Medicines Europe has 49 disclosed EU lobbying meetings from 2024-09-30 to 2026-06-01: 4 with the European Commission and 45 with Members of the European Parliament. Source: EU Transparency Register no. 509882515669-01, Commission disclosures and MEP declarations. Methodology
Affordable Medicines Europe
EU lobbying footprint — who they meet, and on what.
- Register no.
- 509882515669-01 ↗
- Disclosed meetings
- 49 (4 Commission · 45 MEP)
- Period
- 2024-09-30 → 2026-06-01
Declared fields of interest: Business and industry · Competition · Enlargement · Environment · Public health · Single market · Trade
Lobbying profile
as declared 2026-03-11- Category
- Trade and business associations
- Legal status
- AISBL
- Declared lobbying cost
- €500,000
- Lobbying FTEs
- 3
At a glance
- Health2
- Jana Dabbelt1
- Sandra Gallina1
- Vilija Sysaite1
- Dorota Denning1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- MDR/IVDR Revisionsource ↗
- Medical devicessource ↗
- Exchange of views on medical devices regulationsource ↗
- company presentationsource ↗
- CMAsource ↗
- Pharmaceutical Legislationsource ↗
- presentation of the associationsource ↗
- Meeting about CMAsource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- Pharma Packagesource ↗
- CMAsource ↗
- Position and priorities of Europe’s licensed independent medicine distribution sectorsource ↗
- Pharma Packagesource ↗
- 'Single Market for Medicines' initiativesource ↗
- Critical Medicines Actsource ↗
- Pakiet Farmaceutycznysource ↗
- Parallel trade of medicinessource ↗
- 2025-07-02ECSandra Gallina · Director-GeneralEU pharmaceutical regulation and policysource ↗
- Pharma Packagesource ↗
- 2025-07-01ECVilija Sysaite · Cabinet of Executive Vice-President Stéphane SéjournéParallel imports Pharmaceutical legislationsource ↗
- Pharmaceuticalssource ↗
- 2025-06-17ECDorota Denning · Cabinet of Commissioner Valdis DombrovskisSimplification agenda and competitivenesssource ↗
- Critical Medicines Actsource ↗
- Medicines, Pharmaceuticalssource ↗
- Medicine distributionsource ↗
- Health policysource ↗
- shortage of medicinesource ↗
- Priorità per la legislaturasource ↗
- Pharmaceutical productssource ↗
- Ongoing initiativessource ↗
- Critical Medicines Actsource ↗
- Introductory meetingsource ↗
- Pharmaceutical Industrysource ↗
- Exchange on health policy priorities and potential pharmaceutical reforms in the EUsource ↗
- New EU Pharmaceutical Legislationsource ↗
- Pharmaceuticalsource ↗
- Exchange on upcoming Health Policysource ↗
- Medicine shortagessource ↗
- EU Healthcaresource ↗
- Medicinessource ↗
- Medicines accesibilitysource ↗
- Parallel distribution of medicinessource ↗
- Pharmaceutical policysource ↗
- European health policysource ↗
- Dostępność i ceny leków w UEsource ↗
- Health policysource ↗
- Introductionsource ↗
- Pharma regulationsource ↗
- potential reforms in the health sectorsource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Affordable Medicines Europe disclosed?
Affordable Medicines Europe (EU Transparency Register no. 509882515669-01) appears in 49 disclosed meetings with EU officials and MEPs between 2024-09-30 and 2026-06-01: 4 with the European Commission and 45 with Members of the European Parliament.
What does Affordable Medicines Europe lobby on?
Affordable Medicines Europe's disclosed EU meetings most often concern Health. Every meeting and its topic is listed with its official source on this page.
Who does Affordable Medicines Europe meet in Brussels?
Across its disclosed meetings, Affordable Medicines Europe has met Commission officials including Jana Dabbelt, Sandra Gallina, Vilija Sysaite, and MEPs including WÖLKEN Tiemo, JARUBAS Adam, METZ Tilly. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 509882515669-01) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.